1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 27
2.1.3 Impact of Russia-Ukraine Conflict 29
2.1.4 Impact of Israel-Palestine War 31
2.2 Major Growth Drivers 32
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter's Fiver Forces Analysis 43
3 Segmentation of Global Market by Product 47
3.1 Market Overview by Product 47
3.2 Opioids 50
3.3 NSAIDS 51
3.4 Anesthetics 52
3.5 Anticonvulsants 53
3.6 Anti-depressants 54
3.7 Non-narcotic Analgesics 55
4 Segmentation of Global Market by Pain Type 56
4.1 Market Overview by Pain Type 56
4.2 Chronic Pain 59
4.3 Acute Pain 60
5 Segmentation of Global Market by Drug Type 61
5.1 Market Overview by Drug Type 61
5.2 Generic Drugs 64
5.3 Branded Drugs 65
6 Segmentation of Global Market by Route of Administration 66
6.1 Market Overview by Route of Administration 66
6.2 Oral 69
6.3 Parental 70
7 Segmentation of Global Market by Application 71
7.1 Market Overview by Application 71
7.2 Neuropathic Pain 74
7.3 Cancer Pain 75
7.4 Facial Pain and Migraine 76
7.5 Musculoskeletal Pain 77
7.6 Post-operative Pain 78
7.7 Chronic Back Pain 79
7.8 Arthritic Pain 80
7.9 Other Applications 81
8 Segmentation of Global Market by Distribution Channel 82
8.1 Market Overview by Distribution Channel 82
8.2 Hospitals Pharmacy 85
8.3 Online Pharmacy 86
8.4 Retail Pharmacy 87
9 Segmentation of Global Market by Region 88
9.1 Geographic Market Overview 2023-2033 88
9.2 North America Market 2023-2033 by Country 93
9.2.1 Overview of North America Market 93
9.2.2 U.S. 97
9.2.3 Canada 100
9.2.4 Mexico 102
9.3 European Market 2023-2033 by Country 104
9.3.1 Overview of European Market 104
9.3.2 Germany 108
9.3.3 U.K. 110
9.3.4 France 112
9.3.5 Spain 114
9.3.6 Italy 116
9.3.7 Russia 118
9.3.8 Rest of European Market 120
9.4 Asia-Pacific Market 2023-2033 by Country 122
9.4.1 Overview of Asia-Pacific Market 122
9.4.2 Japan 126
9.4.3 China 129
9.4.4 Australia 131
9.4.5 India 133
9.4.6 South Korea 135
9.4.7 Rest of APAC Region 137
9.5 South America Market 2023-2033 by Country 139
9.5.1 Argentina 143
9.5.2 Brazil 145
9.5.3 Chile 147
9.5.4 Rest of South America Market 149
9.6 MEA Market 2023-2033 by Country 150
9.6.1 UAE 154
9.6.2 Saudi Arabia 156
9.6.3 South Africa 158
9.6.4 Other National Markets 160
10 Competitive Landscape 161
10.1 Overview of Key Vendors 161
10.2 New Product Launch, Partnership, Investment, and M&A 164
10.3 Company Profiles 165
Abbott Laboratories Inc. 165
Baxter International Inc. 167
Boehringer Ingelheim International GmbH 168
Eli Lilly & Company 169
GlaxoSmithKline PLC 170
Johnson & Johnson 171
Merck & Co. Inc. 172
Novartis AG 173
Pfizer Inc. 174
Purdue Pharma L.P 175
Teva Pharmaceutical Industries Ltd. 176
11 Investing in Pain Management Drugs Industry: Risk Assessment and Management 177
11.1 Risk Evaluation of Global Market 177
11.2 Critical Success Factors (CSFs) 184
RELATED REPORTS 187